Insider trade report
Open the filing on sec.gov
Cryo-Cell International Inc. (CCEL)
NYSE: CCEL · Services-Misc Health & Allied Services, NEC · Oldsmar, FL · filing with the SEC since 1997
Grade4.5
◀ Past 3.8● Present 5.0▶ Future 4.5
The companyfiscal 2025, as filed
Revenue$31.6M-1.3%
Net income-$2.4M-704.2%
Earnings per share$-0.30-700.0%
Operating cash flow$5.5M-8.9%
Cash$319,031-43.1%
Debt$8.4M-1.5%
Shareholders’ equity-$18.6M-40.8%
Shares, diluted8,068,777-1.8%
Return on equityn/a
The recordfrom its filings
Filings in 202620
Newest filingOct 28 · 4
Annual reportFeb 27, 2026
Quarterly reportOct 9, 2026
Next report due10-K by Feb 28
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted16
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Aug 2026Revenue $31.1MNet income -$1.9MCash from operations $4.9Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Insider trade report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Proxy statement
Open the filing on sec.gov
Annual report to shareholders
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Activist holder update, amended
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.